143 related articles for article (PubMed ID: 21541977)
1. Vitamin D deficiency promotes prostate cancer growth in bone.
Zheng Y; Zhou H; Ooi LL; Snir AD; Dunstan CR; Seibel MJ
Prostate; 2011 Jun; 71(9):1012-21. PubMed ID: 21541977
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasis.
Ooi LL; Zheng Y; Zhou H; Trivedi T; Conigrave AD; Seibel MJ; Dunstan CR
Bone; 2010 Oct; 47(4):795-803. PubMed ID: 20638491
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis.
Ooi LL; Zhou H; Kalak R; Zheng Y; Conigrave AD; Seibel MJ; Dunstan CR
Cancer Res; 2010 Mar; 70(5):1835-44. PubMed ID: 20160035
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
Liu J; Xu K; Wen G; Guo H; Li S; Wu X; Dai R; Sheng Z; Liao E
Bone; 2008 May; 42(5):950-9. PubMed ID: 18337202
[TBL] [Abstract][Full Text] [Related]
5. Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone.
Virk MS; Petrigliano FA; Liu NQ; Chatziioannou AF; Stout D; Kang CO; Dougall WC; Lieberman JR
Bone; 2009 Jan; 44(1):160-7. PubMed ID: 18929692
[TBL] [Abstract][Full Text] [Related]
6. A novel model of bone-metastatic prostate cancer in immunocompetent mice.
Power CA; Pwint H; Chan J; Cho J; Yu Y; Walsh W; Russell PJ
Prostate; 2009 Nov; 69(15):1613-23. PubMed ID: 19585491
[TBL] [Abstract][Full Text] [Related]
7. The effect of osteoprotegerin administration on the intra-tibial growth of the osteoblastic LuCaP 23.1 prostate cancer xenograft.
Kiefer JA; Vessella RL; Quinn JE; Odman AM; Zhang J; Keller ET; Kostenuik PJ; Dunstan CR; Corey E
Clin Exp Metastasis; 2004; 21(5):381-7. PubMed ID: 15672862
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis.
Zheng Y; Zhou H; Brennan K; Blair JM; Modzelewski JR; Seibel MJ; Dunstan CR
Bone; 2007 Feb; 40(2):471-8. PubMed ID: 17092788
[TBL] [Abstract][Full Text] [Related]
9. Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone.
Zheng Y; Zhou H; Modzelewski JR; Kalak R; Blair JM; Seibel MJ; Dunstan CR
Cancer Res; 2007 Oct; 67(19):9542-8. PubMed ID: 17909065
[TBL] [Abstract][Full Text] [Related]
10. Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy.
Jacot W; Pouderoux S; Thezenas S; Chapelle A; Bleuse JP; Romieu G; Lamy PJ
Breast Cancer Res Treat; 2012 Jul; 134(2):709-17. PubMed ID: 22562178
[TBL] [Abstract][Full Text] [Related]
11. Long-term vitamin D deficiency in older adult C57BL/6 mice does not affect bone structure, remodeling and mineralization.
van der Meijden K; Buskermolen J; van Essen HW; Schuurman T; Steegenga WT; Brouwer-Brolsma EM; Langenbach GEJ; van Ruijven LJ; den Heijer M; Lips P; Bravenboer N
J Steroid Biochem Mol Biol; 2016 Nov; 164():344-352. PubMed ID: 26361014
[TBL] [Abstract][Full Text] [Related]
12. Soluble receptor activator of nuclear factor kappaB Fc diminishes prostate cancer progression in bone.
Zhang J; Dai J; Yao Z; Lu Y; Dougall W; Keller ET
Cancer Res; 2003 Nov; 63(22):7883-90. PubMed ID: 14633717
[TBL] [Abstract][Full Text] [Related]
13. The bisphosphonate olpadronate inhibits skeletal prostate cancer progression in a green fluorescent protein nude mouse model.
Yang M; Burton DW; Geller J; Hillegonds DJ; Hastings RH; Deftos LJ; Hoffman RM
Clin Cancer Res; 2006 Apr; 12(8):2602-6. PubMed ID: 16638872
[TBL] [Abstract][Full Text] [Related]
14. Variants of Osteoprotegerin Lacking TRAIL Binding for Therapeutic Bone Remodeling in Osteolytic Malignancies.
Higgs JT; Jarboe JS; Lee JH; Chanda D; Lee CM; Deivanayagam C; Ponnazhagan S
Mol Cancer Res; 2015 May; 13(5):819-27. PubMed ID: 25636966
[TBL] [Abstract][Full Text] [Related]
15. In vivo bone metabolism and ex vivo bone marrow osteoprogenitors in vitamin D-deprived pigs.
Denis I; Cournot G; Lacroix H; Colin C; Zerath E; Pointillart A
Bone; 2000 May; 26(5):491-8. PubMed ID: 10773589
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the RANK/RANKL signaling with osteoprotegerin prevents castration-induced acceleration of bone metastasis in castration-insensitive prostate cancer.
Takayama K; Inoue T; Narita S; Maita S; Huang M; Numakura K; Tsuruta H; Saito M; Maeno A; Satoh S; Tsuchiya N; Habuchi T
Cancer Lett; 2017 Jul; 397():103-110. PubMed ID: 28373003
[TBL] [Abstract][Full Text] [Related]
17. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of skeletal progression of prostate cancer by GFP imaging, X-ray, and serum OPG and PTHrP.
Burton DW; Geller J; Yang M; Jiang P; Barken I; Hastings RH; Hoffman RM; Deftos LJ
Prostate; 2005 Feb; 62(3):275-81. PubMed ID: 15389781
[TBL] [Abstract][Full Text] [Related]
19. The bone remodeling environment is a factor in breast cancer bone metastasis.
Ooi LL; Zheng Y; Stalgis-Bilinski K; Dunstan CR
Bone; 2011 Jan; 48(1):66-70. PubMed ID: 20472107
[TBL] [Abstract][Full Text] [Related]
20. 1,25(OH)
Lu G; Li J; Chu J; Jin S; Fu Z; Miao D; Yin Y
Biomed Pharmacother; 2017 Nov; 95():1033-1039. PubMed ID: 28922720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
